Los DES liberadores de everolimus son más eficaces y menos costosos que los stent metálicos convencionales

Everolimus DES are more effective and less costly than conventional BMS

 Courtesy of Dr. Guillermo Migliaro. Drug eluting stents (DES) represented the greatest technological advance in the treatment of instent restenosis from conventional metallic stents (BMS), especially cobalt chromium everolimus eluting stents (CoCr EES), which have shown an excellent profile, and are mostly safer, compared to first generation DES.   Indeed, several randomized studies and meta-analyzis have<a href="https://solaci.org/en/2017/06/16/everolimus-des-are-more-effective-and-less-costly-than-conventional-bms/" title="Read more" >...</a>

El éxito en una CTO ¿Se relaciona con mayor sobrevida?

Successful CTO: associated to higher survival rate?

Courtesy of Dr. Carlos Fava. The presence of chronic total occlusions (CTO) in coronary angiograms varies between 5% and 30%, depending of the different analyzis. Likewise, they have been associated to higher mortality rate and the need for myocardial revascularization surgery.   The frequency of CTO PCI is low across the different series (3.8%), though<a href="https://solaci.org/en/2017/05/16/successful-cto-associated-to-higher-survival-rate/" title="Read more" >...</a>

TAVI: la estrategia minimalista es favorable en el EPOC severo

TAVR: minimalist strategy Is favorable in severe COPD

Courtesy of Dr. Carlos Fava. The presence of chronic obstructive pulmonary disease (COPD) is a criterion for which patients are ruled out for surgery and proposed as candidates for its current alternative, transcatheter aortic valve replacement (TAVR). A minimalist strategy could benefit this patient group, given the use of conscious sedation instead of general anesthesia.  <a href="https://solaci.org/en/2017/05/14/tavr-minimalist-strategy-is-favorable-in-severe-copd/" title="Read more" >...</a>

Proximal anterior descending artery angioplasty: what are its long-term outcomes?

Courtesy of Dr. Javier Castro. Certain coronary lesions have been historically discouraged for endovascular treatment. Among these can be found left main coronary artery lesions, multivessel disease, and proximal anterior descending artery lesions. As a matter of fact, the latter is actually considered separately as a criterion for choosing the revascularization method. Endovascular treatment of<a href="https://solaci.org/en/2017/04/20/proximal-anterior-descending-artery-angioplasty-what-are-its-long-term-outcomes/" title="Read more" >...</a>

More Evidence For Left Main PCI

Courtesy of Dr. Carlos Fava. Left main coronary artery disease (LMD), has historically been treated with myocardial revascularization surgery (CABG), but for some years now, and with the development of new drug eluting stents (DES), percutaneous coronary intervention (PCI) has been gathering support in this challenging territory.   The study analyzed the SYNTAX and PRECOMBAT<a href="https://solaci.org/en/2016/11/10/more-evidence-for-left-main-pci/" title="Read more" >...</a>

Stroke Predictors in TAVR: CoreValve vs. Sapien

A comprehensive analyzis of cerebrovascular events in major randomized controlled studies on transcatheter aortic valve replacement (TAVR) has shown some interesting data on both risks and timing of stroke in this setting.   The study carried out by Dr. Neal Kleiman, reviewed data on stroke and stroke predictors among 3,687 patients included in the CoreValve<a href="https://solaci.org/en/2016/09/21/stroke-predictors-in-tavr-corevalve-vs-sapien/" title="Read more" >...</a>

Does PCI Improve Survival in Patients with Stable Heart Disease? COURAGE Extended Analysis

Original Title: Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease. Reference: Steven P. Sedlis et al. N Engl J Med 2015;373:1937-46. Courtesy of Dr. Santiago Alonso. Centro Cardiológico Americano. Sanatorio Americano. Montevideo, Uruguay. During a median follow up of 4.6 years, with 2287 stable heart disease or silent ischemia patients,<a href="https://solaci.org/en/2015/12/09/does-pci-improve-survival-in-patients-with-stable-heart-disease-courage-extended-analysis/" title="Read more" >...</a>

Coronary Obstruction after TAVI: dreaded, but rare and solvable

Original title: Coronary Obstruction After Transcatheter Aortic Valve Implantation. A Systematic Review. Reference: Henrique Barbosa Ribeiro et al. J Am Coll Cardiol Intv 2013. Article in press. In the context of Transcatheter Aortic Valve Implantation (TAVI) there can be complications such as conduction disturbances, bleeding, residual aortic insufficiency or vascular complications, all of which have been detailed with<a href="https://solaci.org/en/2013/04/30/coronary-obstruction-after-tavi-dreaded-but-rare-and-solvable/" title="Read more" >...</a>

QFR Analysis of Coronary Lesions with TAVR

While transcatheter aortic valve replacement (TAVR) has shown benefits, significant coronary artery disease affects 50% or more of patients who undergo such procedure. However, it is still unclear which is the best treatment strategy or how to handle this condition. Quantitative flow ratio (QFR) could be a non-invasive option to assess the severity of coronary<a href="https://solaci.org/en/2024/06/29/qfr-analysis-of-coronary-lesions-with-tavr/" title="Read more" >...</a>

ACC 2024 | ORBITA-COSMIC

Coronary sinus reduction (CSR) is a relevant area of study for the treatment of refractory angina, with hopes of improving myocardial perfusion. However, to date, there are no conclusive data. The ORBITA-COSMIC study is a randomized, double-blind, placebo-controlled trial conducted at six centers in the UK. Researchers recruited patients with angina and chronic ischemia who<a href="https://solaci.org/en/2024/04/17/acc-2024-orbita-cosmic-3/" title="Read more" >...</a>